Ani pharmaceuticals announces the fda approval and launch of indomethacin oral suspension, usp

Baudette, minn., jan. 16, 2024 (globe newswire) -- ani pharmaceuticals, inc. (ani or the company) (nasdaq: anip) today announced that it received u.s. food and drug administration (fda) approval for the abbreviated new drug application (anda) for indomethacin oral suspension (os), usp.

ANIP Ratings Summary

ANIP Quant Ranking